Cavalier Investments’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-7,053
| Closed | -$1.21M | – | 175 |
|
|
2018
Q3 | $1.21M | Buy |
7,053
+2,244
| +47% | +$384K | 0.35% | 65 |
|
|
2018
Q2 | $621K | Hold |
4,809
| – | – | 0.21% | 99 |
|
|
2018
Q1 | $495K | Buy |
+4,809
| New | +$495K | 0.17% | 96 |
|
|
2016
Q1 | – | Sell |
-5,290
| Closed | -$358K | – | 120 |
|
|
2015
Q4 | $358K | Buy |
+5,290
| New | +$358K | 0.21% | 75 |
|